ALK-Abelló (Germany)

ALK-Abelló (Germany)

ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for ALK-Abelló (Germany), Germany, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

59%


Total
Publications

155


Total Open
Publications

91


Total
Citations

4.8K


Open Access
Percentage

59%


Total
Publications

155


Total Open
Publications

91


Total
Citations

4.8K

Wikipedia

Website

download

Breakdown

27% 23% 7% 43%

Publisher Open

27%

Both

23%

Other Platform Open

7%

Closed

43%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01234567891011121314Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

37%OA Journal

OA Journal 37%

28

Hybrid 20%

15

No Guarantees 43%

32

Other Platform Open

Institution 57%

26

Domain 46%

21

Other Internet 17%

8

Preprint 7%

3

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
21
doaj.org OAI-PMH Repository
Institution
9
LA Referencia
Institution
7
DOI
Other Internet
5
Unknown Repository
Other Internet
4
Utrecht University
Institution
2
GFZ Helmholtz Centre for Geosciences
Institution
2
bioRxiv
Preprint
2
Uppsala University
Institution
1
University of Zurich
Institution
1
1 / 3

Data updated 12 August 2026

Share

Share

Share